The Journal of Experimental Medicine
ELISpot, FluoroSpot and ELISA kits from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20080300
The Journal of Experimental Medicine, Vol. 205, No. 10, 2207-2220
The Rockefeller University Press, 0022-1007 $30.00
© Zabel et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2668K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zabel, B. A.
Right arrow Articles by Butcher, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zabel, B. A.
Right arrow Articles by Butcher, E. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

 Mast cell–expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis

Brian A. Zabel1, Susumu Nakae2, Luis Zúñiga1, Ji-Yun Kim1, Takao Ohyama1, Carsten Alt1, Junliang Pan1, Hajime Suto2, Dulce Soler3, Samantha J. Allen4, Tracy M. Handel4, Chang Ho Song2,5, Stephen J. Galli2,6, and Eugene C. Butcher1

1 Laboratory of Immunology and Vascular Biology, Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, and Center for Molecular Biology and Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304
2 Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305
3 Inflammation Department, Millennium Pharmaceuticals, Cambridge, MA 02139
4 Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093
5 Department of Anatomy, Chonbuk National University Medical School, Jeonju, Republic of Korea
6 Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305

CORRESPONDENCE Stephen J. Galli: sgalli{at}stanford.edu OR Brian A. Zabel: bazabel{at}alum.mit.edu

Mast cells contribute importantly to both protective and pathological IgE-dependent immune responses. We show that the mast cell–expressed orphan serpentine receptor mCCRL2 is not required for expression of IgE-mediated mast cell–dependent passive cutaneous anaphylaxis but can enhance the tissue swelling and leukocyte infiltrates associated with such reactions in mice. We further identify chemerin as a natural nonsignaling protein ligand for both human and mouse CCRL2. In contrast to other "silent" or professional chemokine interreceptors, chemerin binding does not trigger ligand internalization. Rather, CCRL2 is able to bind the chemoattractant and increase local concentrations of bioactive chemerin, thus providing a link between CCRL2 expression and inflammation via the cell-signaling chemerin receptor CMKLR1.

Abbreviations used: ANOVA, analysis of variance; BMCMCs, BM-derived cultured mast cells; CCRL2, chemokine (CC motif) receptor-like 2; CMKLR1, chemokine-like receptor 1; DNP-HSA, 2,4-DNP-conjugated human serum albumin; GPCR, G protein–coupled receptor; HA, hemagglutinin; PCA, passive cutaneous anaphylaxis.

B. Zabel and S. Nakae contributed equally to this paper.

S. Nakae's present address is National Research Institute for Child Health and Development, Tokyo, Japan.

J.-Y. Kim and J. Pan's present address is Bayer Healthcare Pharmaceuticals, Inc., Berkeley, CA.

T. Ohyama's present address is Daiichi Sankyo Co., Ltd., Tokyo, Japan.

C. Alt's present address is SRI International, Menlo Park, CA.

H. Suto's present address is Atopy Research Center, Juntendo University, Tokyo, Japan.

© 2008 Zabel et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS